Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Regular athletic training causes changes in cardiac structure and function, commonly referred to as athlete’s heart . The character and magnitude of these changes vary with the type and volume of training but may result in parameters of cardiac structure and function that fall outside the normal range for the general population. The echocardiographer should understand the characteristics of athlete’s heart and the normal limits of these changes and, more importantly, understand how to differentiate these changes from those seen in cardiac disease.
This chapter outlines the structural and functional characteristics of the athlete’s heart, particularly as it relates to echocardiographic examination; some of the key clinical dilemmas that may be evaluated using cardiac ultrasound; and how the echocardiographic information can be used to manage patients.
Undertaking regular exercise can change cardiac structure and function to produce a phenotype known as athlete’s heart. The intermittent volume and pressure loading of the heart during training activates gene pathways that result in physiologic cardiac hypertrophy and cardiac chamber enlargement in addition to changes in autonomic tone and cardiac conduction. Athlete’s heart is not one distinct phenotype but a spectrum of changes that vary with the sporting discipline and the intensity with which it is undertaken.
In assessing whether echocardiographic findings are physiologic or pathologic, it is first necessary to decide whether the individual is performing sufficient exercise to produce the heart of an athlete. The changes of athlete’s heart, such as bradycardia, increased aerobic capacity, and increased left ventricular (LV) mass, are usually seen only in individuals undertaking at least 3 hours of moderate-intensity exercise per week. Greater volume and intensity of exercise results in greater degrees of change in cardiac structure and function, such that a fundamental question in the evaluation of an athlete is whether he or she is doing enough exercise of the appropriate volume and intensity to explain the changes seen during echocardiography.
The cardiac diseases that are of concern in athletes and must be distinguished from athlete’s heart are influenced by age. Younger athletes are more likely to be affected by inherited cardiac abnormalities such as hypertrophic cardiomyopathy (HCM), arrhythmogenic cardiomyopathy, and coronary artery anomalies, whereas older athletes (e.g., >35 years of age) are more likely to suffer from acquired cardiac disease, such as coronary artery disease, in addition to the inherited diseases seen in younger athletes.
It is likely that the changes of athlete’s heart are modulated by the effects of aging, but this is incompletely understood. The age at which intense exercise was commenced appears to influence the pattern and extent of the changes of athlete’s heart. Conversely, exercise may modulate the effect of normal aging on cardiac properties. Reduction in the normal age-related decline in LV compliance has been described and is a beneficial manifestation of lifelong exercise.
Sporting disciplines vary markedly in the degree of static (strength) and dynamic (endurance) loads imposed on the heart and the relative intensity of these loads. The concept that different forms of exercise have different effects on the cardiac phenotype produced is known as the Morganroth hypothesis. This has led to classification of sporting disciplines based on the characteristics of the loads imposed. A simplified outline of this classification is presented in Table 35.1 ; a more complete classification is provided in the work of the task force led by Mitchell.
Static Component | Dynamic Component | ||
---|---|---|---|
Low | Medium | High | |
Low | Golf Cricket Bowling |
Baseball Fencing Volleyball |
Hockey Long-distance running Soccer |
Medium | Archery Diving Equestrian events |
American football Jumping events Sprinting Rugby |
Middle-distance running Swimming Basketball Ice hockey Cross-country skiing |
High | Throwing events Weight lifting Gymnastics Martial arts |
Downhill skiing Body building Snowboarding Wrestling |
Cycling Triathlon Rowing Canoeing/Kayaking |
Dynamic exercise places a volume load on the cardiovascular system, with marked increases in cardiac output required during exercise. This is achieved by increasing the heart rate and stroke volume and is accompanied by increased systolic blood pressure, reduced diastolic blood pressure, and only a small increase in mean arterial pressure. Static exercise places a more modest volume load on the cardiovascular system, with small increases in heart rate, but it is characterized by a significant pressure load resulting from elevation of systolic, diastolic, and mean blood pressures.
Traditional teaching aligned with the Morganroth hypothesis has been that endurance-trained athletes develop increased LV cavity volumes and dimensions with a normal wall thickness or with increased thickness in proportion to the LV cavity size (i.e., eccentric left ventricular hypertrophy [LVH]), whereas strength-trained athletes develop increased LV wall thickness (concentric LVH) with relatively normal LV cavity volumes and dimensions. The latter concept has been questioned because studies have failed to demonstrate concentric LVH in strength-trained athletes; LV wall thickness was within normal limits in purely strength-trained adolescents and adults, and LV cavity measures were similar to or only slightly larger than those of sedentary controls in cross-sectional and prospective studies.
It is possible that understanding of the effects of strength training has been clouded by the use of anabolic agents in this athlete group (see Left Ventricle: Structure). The most profound changes in terms of chamber enlargement and increased cardiac mass have been consistently demonstrated in subjects who were engaged in activities involving a combination of significant static and dynamic components, such as rowing, canoeing, and cycling. , , These types of athletes also have a higher prevalence of electrocardiographic (ECG) changes.
Echocardiography has played a critical role in understanding the impact of exercise on the heart and in defining the normal changes in cardiac structure and function associated with athlete’s heart. Precise cutoffs to differentiate between an athlete and a nonathlete are difficult to define because of the different amounts of remodeling seen in athletes with different training backgrounds and the overlap between athletes and nonathletes. Table 35.2 lists suggested normal ranges for quantification of cardiac structure in athletes by gender, age, and racial background.
Parameter | Normal ASE/EACVI Values | Adolescent Caucasian Athlete | Adult Caucasian Athlete | Adolescent Afro-Caribbean Athlete | Adult Afro-Caribbean Athlete |
---|---|---|---|---|---|
Males | |||||
LVWT (mm) | 6–10 | 6–13 (>12) | 7–14 (>12) | 6–14 (>12) | 8–16 (>14) |
LVIDd (mm) | 42–58 | 45–60 (>60) | 42–66 (>60) | 35–62 (>60) | 44–64 (>60) |
RWT | 0.34–0.37 | 0.27–0.43 | 0.37–0.48 | 0.30–0.58 | — |
LV mass (g), linear | 88–224 | 42–465 | 113–489 | 109–329 | 113–618 |
LV mass (g), 2D | 96–200 | 42–465 | — | — | — |
LVEDV (mL) | 62–150 | — | 180–340 (>330) | 65–153 | — |
LVEDVI (mL/m 2 ) | 34–74 | — | — | — | — |
LVEF (%) | 52–72 | — | 41–77 (<45) | 50–76 (<50) | — |
GLS (%) | — | — | 14–21 | — | — |
LA diameter | — | 25–41 (>40) | 29–45 (>45) | 25–44 (>40) | — |
LAVi (mL/m 2 ) | 16–34 | — | 25–57 | — | — |
RVEDV (mL) | — | — | 200–390 (>375) | — | — |
RVEF (%) | — | — | 40–58 (<45) | — | — |
Females | |||||
LVWT (mm) | 6–9 | 6–11 (>10) | 7–11 (>10) | 7–11 (>10) | 6–13 (>11) |
LVIDd (mm) | 38–52 | 41–55 (>55) | 40–66 (>55) | — | 39–60 (>55) |
LV mass (g), linear | 67–162 | 54–268 | 67–261 | — | 95–322 |
LV mass (g), 2D | 66–150 | — | — | — | — |
LVEDV (mL) | 46–106 | — | 140–260 (>260) | — | — |
LVEDVI (mL/m 2 ) | 29–61 | — | — | — | — |
LVEF (%) | 54–74 | — | 44–76 (<45) | — | 41–78 (<45) |
LA diameter | — | 24–40 (>40) | — | 21–41 (>40) | |
LAVi (mL/m 2 ) | 16–34 | — | 17–39 | — | — |
RVEDV (mL) | — | — | 150–290 (>280) | — | — |
RVEF (%) | — | — | 40–67 (<45) | — | — |
a Athletes have not been separated by type of training undertaken. Values likely to be abnormal when further evaluation is indicated are shown in parentheses.
Regular training increases LV mass, with the pattern determined in part by the type of training undertaken by the athlete, as described earlier. For the echocardiographer trying to differentiate physiologic remodeling from cardiac pathology, the key issue is whether the echocardiographic findings fall inside or outside the expected range for the type and intensity of exercise undertaken by the athlete being examined. Most studies that have determined normal ranges for LV structure have used M-mode to measure LV internal diameter at end-diastole and end-systole, septal wall thickness, and posterior wall thickness at end-diastole, with these values used to determine relative wall thickness and often mass. Others have reported LV volume measurements obtained by echocardiography or cardiac magnetic resonance imaging (MRI).
In pure dynamic exercise, LV mass, volume, dimensions, and wall thickness are all increased ; however, the extent of chamber enlargement and the increase in wall thickness tends to be in balance, such that relative wall thickness is similar to that in nonathletes in many studies. In pure static exercise training, LV dimensions are normal or mildly increased with normal or increased wall thickness. The commonly held view that a concentric pattern of hypertrophy is seen as a result of strength training is incorrect, and a smaller than normal LV cavity should raise the possibility of HCM.
The most profound changes are seen in athletes undertaking endurance and strength training, such as cyclists and rowers. Most studies have found these athletes to have the greatest LV mass and largest dimensions. Many studies are carried out in recreational athletes, and the changes seen in elite and professional athletes can be quite profound when compared with the ranges presented in many cross-sectional studies ( Fig. 35.1 ).
The parameters of cardiac structure most commonly used to differentiate healthy athletes from those with inherited cardiac disease such as HCM have been measures of LV wall thickness and relative wall thickness. Wall thickness less than 13 mm in males or less than 11 mm in females is considered to be normal for an athlete ( Fig. 35.2 ). Wall thicknesses greater than 15 mm in a black male athlete, 14 mm in a white male athlete, and 13 mm in a female athlete are considered to be abnormal. This leaves a “gray zone” between these values where differentiation of physiology from pathology may be necessary.
It is clear that gender, age, and race have effects on the athlete’s heart phenotype. Although the direction of change with training is similar, dimensions, wall thickness, and LV mass are lower in females than in males, even when indexing for body surface area (BSA) is performed. However, published data on cardiac dimensions in female athletes, particularly elite female endurance athletes, are sparse. Whether female athletes undertaking high intensities and volumes of exercise similar to those of male athletes may develop similarly profound adaptations is a question that requires further research. Different normal ranges are employed for female athletes (see Table 35.2 ).
Adolescent athletes tend to have less developed changes of athlete’s heart that become more pronounced during maturation, leading to different published normal ranges for younger athletes (see Table 35.2 ). Whether these differences are truly attributable to cardiac maturation or simply to the lower volume of training exposure compared with adults is unknown. Adolescent cohorts in these publications have been largely subelite nonendurance athletes; data are lacking on the cardiac adaptations in populations of elite adolescent athletes, who may have already undergone 3 to 4 years of intensive endurance training.
Athletes of Afro-Caribbean background have increased wall thickness compared with white athletes, and different ranges are used to define normality. For example, the upper limit of normal wall thickness in a white male athlete is 12 mm, but it may be up to 15 mm in healthy Afro-Caribbean male athletes (see Fig. 35.2 ). Wall thickness in black female athletes is also greater than in their white counterparts. Wall thickness greater than 11 mm is unusual in white female athletes, but wall thickness up to 13 mm is seen in black female athletes.
Determining the impact of performance-enhancing drugs on cardiac structure and function is difficult because most athletes are reluctant to admit to their use. Studies using cardiac MRI and echocardiography have shown that strength-trained athletes who do not use anabolic steroids have LV wall thicknesses, ventricular volumes, and left ventricular ejection fractions (LVEFs) similar to those of nonathletes. In contrast, users of anabolic steroids have larger LV volumes, thicker walls, and lower LVEFs compared with nonathletes and with strength-trained athletes not using steroids. Echocardiographic studies have also suggested that anabolic steroid use produces abnormalities in Doppler measures of LV systolic function and diastolic function. It is therefore likely that pure strength training is not truly associated with significant changes in measures of LV structure and that published normal cardiac findings for purely strength-trained athletes have been affected by undeclared use of anabolic steroids.
Two large meta-analyses reported similar LVEF values for athletes and the general population. , However, lower than normal resting LVEF with preserved stroke volumes can be observed in healthy elite endurance athletes, in whom profound increases in volumes affect all four cardiac chambers. In other words, a healthy enlarged LV needs less vigorous contraction and a lower LVEF to maintain normal cardiac output at rest ( Fig. 35.3 ). The same finding has been observed in elite athletes with nondilated ventricles. In cases of uncertainty, imaging of the heart during exercise may be helpful to differentiate a dilated athlete’s heart from a dilated cardiomyopathy (DCM) (see Technical Considerations and Physiologic Differences).
Less is known about the effect of athletic activity on direct measures of myocardial function, such as tissue velocity, strain, and strain rate. Most studies have reported normal or supranormal LV myocardial systolic velocities at rest in athletes. , A cutoff value of 9 cm/s of systolic peak velocity ( s ′, averaged over four mitral annular sites) has been proposed as an accurate discriminator between pathologic LVH and athlete’s heart. However, athletes with HCM may have preserved myocardial velocities. Therefore, when there is a clinical suspicion of HCM, normal systolic myocardial velocities should not be used as a discriminator between HCM and athlete’s heart.
Resting global longitudinal strain measures have been reported to be lower in athletic cohorts compared with nonathletic controls. In much the same way as LVEF may appear reduced at rest in healthy endurance athletes, these observations likely reflect the inadequacy of resting measures to assess functional reserve; lower strain velocities may be required at rest to maintain normal stroke volumes in physiologically enlarged hearts. This has been eloquently demonstrated in the right ventricle (RV), with lower RV strain rates at rest in endurance athletes than in controls but normal augmentation of these indices with exercise. In the absence of normative values in large populations of athletes from a spectrum of sporting disciplines, these measures are not currently considered routine in the assessment of the athlete’s heart but may prove to be useful in the future, particularly in the assessment of cardiac reserve with stress echocardiography ( Fig. 35.4 ).
Resting measures of LV diastolic function are typically normal or supranormal in athletes, who demonstrate higher LV chamber compliance than sedentary controls. , Increases in measures of early diastolic function (i.e., peak transmitral E-wave and E′ tissue velocities) and late diastolic indices (i.e., peak transmitral A-wave and A′ velocity) appear to be most marked in endurance athletes. Although cutoffs for diastolic parameters (e.g., E/ e ′ > 7.3) have been proposed for discrimination between athlete’s heart and pathologic LVH, normal diastolic parameters may be observed in athletes with HCM. Although abnormal diastolic filling detected by echocardiography in an athlete is likely to reflect myocardial disease, diastolic filling in the normal range for nonathletes does not exclude disease.
During exercise, the RV is subjected to the same volume load as the LV, but wall stress increases more in the RV due to increases in pulmonary artery pressure that parallel the increased cardiac output. Compared with nonathletes, athletes have increased RV volume, increased RV linear dimensions, and increased wall thickness. The magnitude of the increase in RV volume with training is similar to the increase in LV volume, and some reports suggest that it is slightly greater. This has been seen with both strength- and endurance-trained athletes. The degree of RV remodeling increases with duration of training, with more profound changes seen in older athletes with longer participation.
At a practical level, the use of a focused RV view is important for examining the RV, identifying the free wall and the trabeculae, and quantifying dimensions and area ( Fig. 35.5 ).
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here